Fexofenadine/Pseudoephedrine tablets recalled for failed dissolution
Dr. Reddy's Laboratories is recalling Kroger Allergy Relief-D tablets (fexofenadine HCl 60mg/pseudoephedrine HCl 120mg) due to failed dissolution specifications. Approximately 11,064 boxes distributed nationwide are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall. The source text identifies only a failed dissolution specification without reports of illness or injury. No clinical harm has been reported, making this a precautionary recall grounded in a manufacturing or quality-control issue rather than confirmed adverse events.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Kroger Allergy Relief-D Extended-Release Tablets, which contain fexofenadine HCl 60mg (antihistamine) and pseudoephedrine HCl 120mg (nasal decongestant), due to failed dissolution specifications. The affected product is NDC 30142-611-14, 20 tablets per box, manufactured in India and distributed by the Kroger Co.
Approximately 11,064 boxes with the following lot numbers have been distributed nationwide: AC2000968E (expiration 8/31/2022), AC2103328A (expiration 1/31/2023), AC2103330I (expiration 1/31/2023), and AC2106452B (expiration 3/31/2023).
Consumers who have purchased this product should stop using it and dispose of it safely. Persons with questions about this recall may contact Dr. Reddy's Laboratories or consult a healthcare provider.
The recalled product
- Product
- FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI (FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI)
- Brand
- FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- failed-dissolution
- quality-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #s: AC2000968E
- Exp. 8/31/2022
- AC2103328A
- AC2103330I
- Exp. 1/31/2023
- AC2106452B
- Exp. 3/31/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI
- LowWal-Fex D Allergy and Decongestant Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-01-26
- ModerateOTC Allergy and Congestion Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2021-12-15
- LowFexofenadine and Pseudoephedrine Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2021-12-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27